This content is machine translated The Brain and the Motivation to Eat Why is it so hard to lose weight? Obesity is the most common chronic disease in Western societies, with serious metabolic, cardiovascular, and psychosocial consequences. The therapeutic landscape has changed fundamentally: new-generation GLP-1 agonists achieve weight loss that,...… CME-Test
View Post 12 min This content is machine translated Global Recommendation, Swissmedic Approval, and SL Limitation WHO Guidelines on GLP-1 for Obesity With the guideline published on December 1, 2025, the World Health Organization has, for the first time, issued a globally applicable recommendation on the pharmacological management of obesity in adults....…
View Post 13 min This content is machine translated Obesity Treatment Oral GLP-1 Therapies: ATTAIN-1 and OASIS-4—The Next Leap Forward Injectable GLP-1 receptor agonists and the dual GIP/GLP-1 agonist tirzepatide have redefined pharmacological obesity treatment and achieved weight loss in the range of 15 to 20% in clinical trials. Nevertheless,...…
View Post 12 min This content is machine translated Cardiology and Nutrition Ultra-Processed Foods and Cardiovascular Risk—The New AHA Position Ultra-processed foods (UPFs ) account for a significant portion of energy intake in Western countries—in the United States, an estimated more than half. Given this ubiquity and a growing number...…
View Post 11 min This content is machine translated Cardiometabolism Retatrutid and the TRIUMPH Program: The Triple Agonist on the Horizon Incretin-based obesity therapy has advanced rapidly in just a few years: from GLP-1 receptor agonists (semaglutide) to the dual GIP/GLP-1 agonist tirzepatide and on to a triple agonist. Retatrutide (LY3437943)...…
View Post 12 min This content is machine translated Hepatology and Metabolism The Mediterranean Diet for MASLD/MASH—What the EASL-EASD-EASO Guidelines Specifically Recommend Since an international Delphi consensus in 2023, the condition formerly known as nonalcoholic fatty liver disease (NAFLD) has been called MASLD— “metabolic dysfunction-associated steatotic liver disease.” It is defined as...…
View Post 3 min This content is machine translated Shaping the Future with LLM & Co. AI in Everyday Clinical Practice: Friend or Foe? Artificial intelligence (AI) has long been more than just a vision of the future in medicine. AI systems not only have the potential to support documentation and analyze large amounts...…
View Post 3 min This content is machine translated IBD in childhood Pneumococcal vaccination without negative consequences Inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis are characterized by a relapsing-remitting course in which infectious diseases are considered important triggers for disease flare-ups. Although vaccination is...…
View Post 38 min This content is machine translated Psychological dependence on AI assistants, smartphones and short videos Algorithms, avatars and the unburdened mind Three digital behavioral patterns characterize the reality of modern patient use and are converging into a clinically relevant phenomenon in medical consultations: problematic smartphone use, the continuous consumption of short...… CME-Test
View Post 6 min This content is machine translated Analysis of SNVCS data from the period 2005-2022 TBE vaccination for children and adolescents in Switzerland The Swiss National Vaccination Study (SNVCS) is a nationwide cross-sectional study that evaluates the vaccination rate of children and adolescents aged 2, 8 and 16 years. In a combined cross-sectional...…
View Post 11 min This content is machine translated Peristomal skin health Focus on preventive care options For people with a stoma, peristomal skin health is a key factor for quality of life. With an incidence of up to over 70%, skin complications in the stoma area...… CME-Test
